The statement was written to fill gaps in recommendations from prior consensus statements and guidelines in regards to the use of CCT in cardio-oncology, including use of calcium scoring and ruling out coronary disease when cardiac function is impaired.

The treatment has the potential to “extend lifespans and improve quality of life” in patients with brain cancer, according to experts at UC San Diego Health. 

Adoption of PSMA-PET has been swift because it can significantly improve prostate cancer detection and treatment. SNMMI President Munir Ghesani, MD, explains how.

In a close collaboration with radiation oncologists, experts trained their model on the CT lung images of 787 patients and tested it on the scans of more than 1,300 patients from external datasets.

The new hydrogel material was designed to immediately conform to the patient's body and create a barrier.

The authors stated that their results should not deter providers from offering their patients radiotherapy treatment but rather encourage in-depth discussions and shared decisions pertaining to the best options.

A cancer-care technology company that was acquired by one of the world’s largest imaging OEMs a year ago has received an Investigational Device Exemption from the FDA.

PET/CT imaging in these patients increases overall survival depending on the cancer’s stage, with those diagnosed with stage 3A and 3B NSCLC appearing to benefit the most from the exam.